Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Drug Hypersensitivity
Interventions
DRUG

Vitrase

Trial Locations (1)

95616

Solano Clinical Research (A Division of Dow Pharmaceutical Sciences), Davis

All Listed Sponsors
lead

Bausch & Lomb Incorporated

INDUSTRY

NCT00198419 - Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase) | Biotech Hunter | Biotech Hunter